TRPM8 and osteosarcoma: The first study analyzing TRP channels in sarcomas reported a marked increase of the expression of the TRP melastatin (TRPM8) subfamily in patients with osteosarcoma at a higher clinical stage compared to those with a lower clinical stage and the absence of metastasis [34].